Abstract:Background: Inflammation is a significant residual risk factor for coronary artery disease. While intensive lipid-lowering therapy has reduced the prevalence of plaque rupture, plaque erosion in acute coronary syndrome (ACS) patients is increasing, with neutrophils playing a crucial role. It remains unclear whether varying low-density lipoprotein cholesterol (LDL-C) levels modify the relationship between neutrophil count and ischemic risk in ACS patients. Aim: To investigate the relationship between neutrophil counts and ischemic risk in ACS patients undergoing percutaneous coronary intervention (PCI) across different LDL-C levels. Methods: This large cohort study enrolled consecutive 10724 patients undergoing PCI at Fuwai Hospital (Peking Union Medical College) throughout the year of 2013. Patients were divided into subgroups according to baseline LDL-C levels, with cut-off points at 1.8mmol/L or 1.4mmol/L. The primary endpoint was major adverse cardiovascular event (MACE), and the secondary endpoint was revascularization. Results: Finally, 5717 ACS patients with PCI were included. The mean age was 58.43 ± 10.35 years, with 4399 (76.9%) being male. During the 5-year follow-up period, 1058 (18.5%) MACEs and 821 (14.4%) revascularizations were recorded. Restricted cubic spline analysis revealed a positive correlation between neutrophil and MACE and revascularizations only in patients with lower LDL-C levels (LDL-C <1.8 and LDL-C <1.4 mmol/L), but not in those with higher LDL-C levels (LDL-C ≥1.8 and LDL-C ≥1.4 mmol/L) (Figure 1) . Multivariate Cox regression analysis showed that in the LDL-C <1.8 mmol/L group, each unit increase in neutrophil count was associated with a 1.129 times higher risk of MACE (HR 1.129; 95% CI 1.046-1.219) and a 1.130 times higher risk of revascularizations (HR 1.130; 95% CI 1.031-1.238). Similar findings were observed in the LDL-C <1.4 mmol/L group, where higher neutrophil was independent risk factors for MACE (HR 1.222; 95% CI 1.063-1.404) and revascularizations (HR 1.274; 95% CI 1.078-1.506). However, in patients with higher LDL-C levels (LDL-C ≥1.8 and LDL-C ≥1.4 mmol/L), neutrophil counts were not associated with outcomes (Table 1) . Conclusions： High neutrophil counts are a significant risk factor for ischemic events in ACS patients with low LDL-C levels, highlighting the potential benefits of targeting neutrophils-related inflammatory pathway in the management of ACS patients with well-controlled LDL-C levels.

High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk

Predictive value of the relative lymphocyte count in coronary heart disease

Association Between Circulating Leukocytes and Arrhythmias: Mendelian Randomization Analysis in Immuno-Cardiac Electrophysiology

Variability in Non-HDL-C and Lp(a) Affect the Neutrophil to Lymphocyte Ratio in Patients Undergoing Elective Percutaneous Coronary Intervention

Higher monocyte count with normal white blood cell count is positively associated with 10-year cardiovascular disease risk determined by Framingham risk score among community-dwelling Korean individuals

Peripheral leukocyte counts vary with lipid levels, age and sex in subjects from the healthy population

Leukocyte Count and Adverse Clinical Outcomes in Acute Ischemic Stroke Patients

Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?

Relationship Between Leukocyte Count and Angiographical Characteristics of Coronary Atherosclerosis

Leukocyte as an Independent Predictor of Lower-Extremity Deep Venous Thrombosis in Elderly Patients With Primary Intracerebral Hemorrhage

The white blood cell count and risk for coronary heart disease

Predictive Value of Leukocyte Count for Cardiovascular Events in Patients with Unstable Angina Pectoris

Causal association between blood leukocyte counts and vascular dementia: a two-sample bidirectional Mendelian randomization study

Abstract 4140810: Impact of Neutrophil on Ischemic Risk in Acute Coronary Syndrome Patients Across Different Low Density Lipoprotein Cholesterol Levels

White blood cell counts can predict 4-year cardiovascular disease risk in patients with stable coronary heart disease: a prospective cohort study

White blood cell count predicts the odds of kidney function decline in a Chinese community-based population

Decreased lymphocyte and increased monocyte count in peripheral blood is associated with cardiovascular disease and one-year mortality in maintenance hemodialysis patients

Association of White Blood Cell Counts with Left Ventricular Mass Index in Hypertensive Patients Undergoing Anti-Hypertensive Drug Therapy

Association between the variability of non-high-density lipoprotein cholesterol and the neutrophil-to-lymphocyte ratio in patients with coronary heart disease

Association of Peripheral Differential Leukocyte Counts with Dyslipidemia Risk in Chinese Patients with Hypertension: Insight from the China Stroke Primary Prevention Trial

Variability in blood lipids affects the neutrophil to lymphocyte ratio in patients undergoing elective percutaneous coronary intervention: a retrospective study